Huyabio International, Llc.

This early-stage study is testing a new oral medication called HBI-2438 in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find the highest safe dose and understand how the body processes the drug. It includes 44 adult…

This study is testing whether adding an oral drug called HBI-8000 to the standard immunotherapy nivolumab works better than nivolumab alone for advanced melanoma that cannot be surgically removed. The trial involves 450 adults and adolescents with this type of skin cancer who hav…

This early-stage study is testing a new oral medication called HBI-2376 in people with advanced solid tumors that have specific KRAS or EGFR mutations. The main goals are to find the highest safe dose of the drug and to understand how the body absorbs and processes it. The trial …

This study is testing a new drug called HBI-3000, given as a single 30-minute IV infusion, to see if it can safely and effectively restore a normal heart rhythm in people who have recently developed atrial fibrillation (AF). The trial has two parts: first, to find the best dose, …